Amy Sheridan-Hill, co-founder of the H-ABC Foundation, and Dan Williams in major Mirror story about hopes for new drugDr Dan WilliamsOct 31, 20241 min readRead the Mirror news story about the H-ABC Foundation and SynaptixBio here.
Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design
Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.
Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis
Comments